PROCEPT BioRobotics Corporation (PRCT) Financials

PRCT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 479.4 million 139.3 million
March 31, 2026 487.1 million 139.4 million
Dec. 31, 2025 508.1 million 142.2 million
Sept. 30, 2025 511.5 million 131.3 million

PRCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -63.2 million 27.6 million
March 31, 2026 -41.0 million 13.1 million
Dec. 31, 2025 -12.2 million 10.8 million
Sept. 30, 2025 -9.5 million 14.5 million

PRCT Net Income

No data available :(

PRCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 227.9 million 51.7 million 25.8 million
March 31, 2026 245.6 million 51.7 million 24.0 million
Dec. 31, 2025 286.5 million 51.6 million 24.7 million
Sept. 30, 2025 294.3 million 51.6 million 25.2 million

PRCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 56.5 million
March 31, 2026 56.5 million
Dec. 31, 2025 56.1 million
Sept. 30, 2025 55.7 million

PRCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5.9 million 20.1 million 69.7 million -
March 31, 2026 2.9 million 21.5 million 65.1 million -
Dec. 31, 2025 1.9 million 19.1 million 58.3 million -
Sept. 30, 2025 2.9 million 16.6 million 59.0 million -

PRCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 94.5 million 32.1 million
March 31, 2026 83.1 million 29.2 million
Dec. 31, 2025 76.4 million 30.1 million
Sept. 30, 2025 83.3 million 30.9 million

PRCT

Price: $21.09

52 week price:
16.67
49.90

Earnings Per Share: -1.95 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 249300

Market Capitalization: 1.2 billion

Links: